Bronx Hospital First in NYC to Deploy ZOLL Autopulse.CHELMSFORD, Mass. -- ZOLL Medical Corporation (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : ZOLL), a manufacturer of resuscitation resuscitation /re·sus·ci·ta·tion/ (-sus?i-ta´shun) restoration to life of one apparently dead. cardiopulmonary resuscitation devices and related software solutions, today reported that Our Lady of Mercy (OLM olm: see mud puppy. ) Medical Center's paramedic ambulance has deployed the ZOLL AutoPulse(R) Non-invasive Cardiac Support Pump. OLM EMS is the first 911 ambulance in New York City New York City: see New York, city. New York City City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S. to deploy the device, which automates the performance of CPR Cardiopulmonary Resuscitation (CPR) Definition Cardiopulmonary resuscitation (CPR) is a procedure to support and maintain breathing and circulation for a person who has stopped breathing (respiratory arrest) and/or whose heart has stopped (cardiac chest compressions. OLM EMS Emergency Services Director Michael Moculski noted in a recent New York Daily News New York Daily News Morning daily tabloid newspaper published in New York City. It was founded in 1919 by Joseph Medill Patterson and his cousin Robert McCormick as a subsidiary of the Tribune Co. of Chicago. The first successful tabloid-format newspaper in the U.S. article that the AutoPulse will "keep on doing CPR without stopping. There's no fatigue for the rescue worker. It doesn't have to stop to go up and down stairs." Such continuous CPR performance can help improve blood flow to the heart and brain of a cardiac arrest victim. About the AutoPulse The major emphasis of recently released American Heart Association American Heart Association (AHA), n.pr a national voluntary health agency that has the goal of increasing public and medical awareness of cardiovascular diseases and stroke, and thereby reducing the number of associated deaths and disabilities. 2005 Guidelines is performing effective, high-quality CPR. The 2005 Guidelines now recommend 30 compressions for every two rescue breaths--an increase from 15 compressions for every two breaths in the 2000 Guidelines. Furthermore, the Guidelines note that interrupting chest compressions can decrease the rate of survival from cardiac arrest.(1) The AutoPulse is an automated, portable device with a simple, load-distributing LifeBand(R) that squeezes the entire chest in a consistent, uninterrupted "hands-free" manner, delivering maximum blood flow to the heart and brain.* Additionally, it offers the benefit of freeing up rescuers to focus on other life-saving interventions. About ZOLL Medical Corporation ZOLL Medical Corporation is committed to developing technologies that help advance the practice of resuscitation. With products for pacing, defibrillation Defibrillation Definition Defibrillation is a process in which an electronic device sends an electric shock to the heart to stop an extremely rapid, irregular heartbeat, and restore the normal heart rhythm. , circulation, ventilation, and fluid resuscitation, ZOLL provides a comprehensive set of technologies that help clinicians, EMS professionals, and lay rescuers resuscitate re·sus·ci·tate v. To restore consciousness, vigor, or life to. sudden cardiac arrest or trauma victims. ZOLL also designs and markets software that automates the documentation and management of both clinical and non-clinical information. ZOLL markets and sells its products in more than 140 countries. The Company has direct operations, distributor networks, and business partners throughout the U.S., Canada, Latin America, Europe, the Middle East, Asia, and Australia. For more information, visit www.zoll.com or call +1 (978) 421-9655. Certain statements contained in this press release regarding matters that are not historical facts are "forward-looking" statements (as defined in the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995). Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, ZOLL's ability to compete in the resuscitation business; acceptance of its recently launched products; changes in regulations affecting the healthcare industry; global economic conditions; and those other factors discussed in the section entitled "Risk Factors" in ZOLL's Quarterly Report on Form 10-Q, which was filed with the SEC on August 11, 2006. (C)2006 ZOLL Medical Corporation. All rights reserved. 269 Mill Road, Chelmsford, MA 01824-4105. AutoPulse, LifeBand, and ZOLL are registered trademarks of ZOLL Medical Corporation. All product names are the property of their respective owners. (1)Clinical data available upon request. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion